Quick Facts at a Glance
- Recall Date
- December 19, 2025
- Hazard Level
- HIGH
- Brands
- Wegovy, Novo Nordisk
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- Wegovy, Novo Nordisk
- Product type
- Injection
- Model numbers
- Lot #: RZFHD52, RZFHW93, Exp Date 10/31/2026
- UPC codes
- 0169-4404, 0169-4525, 0169-4505, 0169-4501, 0169-4517, 0169-4524, 0169-4415, 0169-4409 +11 more
- Sold at
- Multiple Retailers
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
December 19, 2025
Reported by FDA DRUG
January 7, 2026
RecallRadar source check
January 14, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Presence of Particulate Matter: Hair was found in a prefilled syringe
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Novo Nordisk Inc. or your healthcare provider for guidance. Notification method: Letter
About This Product
Wegovy is a prescription medication used for weight management in adults. It is administered via injection and helps regulate appetite and caloric intake.
Why This Is Dangerous
The presence of hair in the syringe poses a contamination risk that could lead to infections or other health complications if injected.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Consumers are urged to stop using this product to avoid serious health risks associated with contamination.
Practical Guidance
How to identify if yours is affected
- Check the lot number on your Wegovy injection pens.
- Verify if the lot number is RZFHD52 or RZFHW93.
- Confirm the expiration date is October 31, 2026.
Where to find product info
The lot number and expiration date can typically be found on the product packaging.
What timeline to expect
Expect a refund or replacement within 4-6 weeks after returning the product.
If the manufacturer is unresponsive
- Follow up with Novo Nordisk if you do not receive a response within a week.
- Document all communications with the company.
How to prevent similar issues
- Always inspect the packaging and syringe before use.
- Be aware of recalls related to medications and injectables.
- Consult your healthcare provider for alternatives if recalls occur.
Documentation advice
Keep a record of your purchase, any communications with Novo Nordisk, and photographs of the product for reference.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
The recall involves Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, packaged as 4 Single-Dose Prefilled Pens. The affected lot numbers are RZFHD52 and RZFHW93, with an expiration date of October 31, 2026. The product was distributed throughout the United States.
Key Facts
- Recall date: December 19, 2025
- Reported contamination: Hair found in prefilled syringes
- Health classification: Class II
- Manufactured by: Novo Nordisk A/S, Denmark
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.
